news, stories, information, & support
The previous post about the Scenesse treatment has sparked a lot of interest and many questions about the process. I was contacted by phone this week by a Director from Clinuvel. We had a wonderful conversation; most impressive was
Read the full story »
Vitiligo is a quite common skin disease…
We have some idea of what is happening in vitiligo…
The main sign of vitiligo is pigment loss…
vitiligo need not prevent you from doing what you want…
A drug initially developed to protect skin from light and UV will soon be tested as a repigmentation therapy in vitiligo
ReCell® is a stand-alone, rapid, autologous cell harvesting, processing and delivery technology that enables surgeons and clinicians to treat skin defects using the patient’s own cells in a regenerative process. (Vitiligo results here, about halfway down page)
Developed as an ‘off the shelf’ kit, ReCell enables a thin split thickness biopsy, taken at the time of the procedure, to be processed into an immediate cell population for delivery onto the surface of the treatment area using a highly efficient, easy-to-use proprietary ’spray-on’ application process. …
It is my great pleasure to share with you some fantastic repigmentation results sent in by Bryn.
Published Date: 23 April 2010
People with vitiligo “may have natural protection against skin cancer”, according to BBC News. The condition, which causes pale skin patches due to a loss of pigment, was previously assumed to increase the risk of serious skin cancers, such as malignant melanoma.
